Skip to main content
Top
Published in: Urolithiasis 1/2011

01-02-2011 | Original Paper

Lithogenic activity and clinical relevance of lipids extracted from urines and stones of nephrolithiasis patients

Authors: Chanchai Boonla, Phantip Youngjermchan, Somkiat Pumpaisanchai, Kriang Tungsanga, Piyaratana Tosukhowong

Published in: Urolithiasis | Issue 1/2011

Login to get access

Abstract

We investigated contents and classes of urinary and stone matrix lipids, and evaluated their clinical relevance in nephrolithiasis patients. Lithogenic role of major lipid classes was explored. Urine (24 h) and stone samples were collected from 47 patients with nephrolithiasis. Control urines were obtained from 29 healthy subjects. Urinary 8-hydroxy-deoxyguanosine (8-OHdG), malondialdehyde (MDA), N-acetyl-β-glucosaminidase (NAG) activity and total proteins were measured. Total lipids were extracted from centrifuged urines (10,000 rpm, 30 min) and stones by chloroform/methanol method. Major classes of lipids were identified using multi-one-dimensional thin-layer chromatography (MOD-TLC). Influence of each lipid class purified from stone matrices on stone formation was evaluated using crystallization and crystal aggregation assays. Urinary NAG activity and 8-OHdG were significantly elevated in nephrolithiasis patients. Total lipids in centrifuged urines of the patients were not significantly different from that of controls. In nephrolithiasis, urinary excretion of total lipids was linearly correlated to urinary MDA, 8-OHdG, NAG activity and total proteins. Lipid contents in stone matrices varied among stone types. Uric acid stone contained lower amount of total lipids than calcium oxalate and magnesium ammonium phosphate stones. MOD-TLC lipid chromatograms of healthy urines, nephrolithiasis urines and stone matrices were obviously different. Triacylglyceride was abundant in urines, but scarcely found in stone matrices. Stone matrices were rich in glycolipids and high-polar lipids (phospholipids/gangliosides). Partially purified glycolipids significantly induced crystal aggregation while cholesterol was a significant inducer of both crystal formation and agglomeration. In conclusion, total lipids in centrifuged urines did not differ between nephrolithiasis and healthy subjects. Our finding suggests that the significant sources of lipids in patients’ urine may be large lipids-containing particles, which are removed in centrifuged urines. However, urinary lipid excretion in nephrolithiasis patients was associated with the extent of oxidative stress and renal tubular injury. Triacylglyceride was abundant in urines, but rarely incorporated into stones. Glycolipids were principal lipid constituents in stone matrices and functioned as crystal aggregator. Cholesterol purified from stone matrices bared crystal nucleating and aggregating activities.
Literature
1.
go back to reference Tosukhowong P, Boonla C, Ratchanon S, Tanthanuch M, Poonpirome K, Supataravanich P, Dissayabutra T, Tungsanga K (2007) Crystalline composition and etiologic factors of kidney stone in Thailand: update 2007. Asian Biomed 1:87–95 Tosukhowong P, Boonla C, Ratchanon S, Tanthanuch M, Poonpirome K, Supataravanich P, Dissayabutra T, Tungsanga K (2007) Crystalline composition and etiologic factors of kidney stone in Thailand: update 2007. Asian Biomed 1:87–95
2.
go back to reference Jungers P, Joly D, Barbey F, Choukroun G, Daudon M (2004) ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 44:799–805PubMed Jungers P, Joly D, Barbey F, Choukroun G, Daudon M (2004) ESRD caused by nephrolithiasis: prevalence, mechanisms, and prevention. Am J Kidney Dis 44:799–805PubMed
3.
go back to reference Cheng PT, Reid AD, Pritzker KP (1985) Ultrastructural studies of crystal-organic matrix relations in renal stones. Scan Electron Microsc (Pt 1):201–207 Cheng PT, Reid AD, Pritzker KP (1985) Ultrastructural studies of crystal-organic matrix relations in renal stones. Scan Electron Microsc (Pt 1):201–207
4.
go back to reference Khan SR (1995) Heterogeneous nucleation of calcium oxalate crystals in mammalian urine. Scan Microsc 9:597–614 discussion 614–616 Khan SR (1995) Heterogeneous nucleation of calcium oxalate crystals in mammalian urine. Scan Microsc 9:597–614 discussion 614–616
6.
go back to reference Fleming DE, Van Riessen A, Chauvet MC, Grover PK, Hunter B, van Bronswijk W, Ryall RL (2003) Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate. J Bone Miner Res 18:1282–1291CrossRefPubMed Fleming DE, Van Riessen A, Chauvet MC, Grover PK, Hunter B, van Bronswijk W, Ryall RL (2003) Intracrystalline proteins and urolithiasis: a synchrotron X-ray diffraction study of calcium oxalate monohydrate. J Bone Miner Res 18:1282–1291CrossRefPubMed
7.
go back to reference Grover PK, Thurgood LA, Fleming DE, van Bronswijk W, Wang T, Ryall RL (2008) Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured renal cells. Am J Physiol Renal Physiol 294:F355–F361CrossRefPubMed Grover PK, Thurgood LA, Fleming DE, van Bronswijk W, Wang T, Ryall RL (2008) Intracrystalline urinary proteins facilitate degradation and dissolution of calcium oxalate crystals in cultured renal cells. Am J Physiol Renal Physiol 294:F355–F361CrossRefPubMed
8.
go back to reference Kim KM (1983) Lipid matrix of dystrophic calcification and urinary stone. Scan Electron Microsc (Pt 3):1275–1284 Kim KM (1983) Lipid matrix of dystrophic calcification and urinary stone. Scan Electron Microsc (Pt 3):1275–1284
9.
go back to reference Khan SR, Shevock PN, Hackett RL (1988) Presence of lipids in urinary stones: results of preliminary studies. Calcif Tissue Int 42:91–96CrossRefPubMed Khan SR, Shevock PN, Hackett RL (1988) Presence of lipids in urinary stones: results of preliminary studies. Calcif Tissue Int 42:91–96CrossRefPubMed
10.
go back to reference Khan SR, Atmani F, Glenton P, Hou Z, Talham DR, Khurshid M (1996) Lipids and membranes in the organic matrix of urinary calcific crystals and stones. Calcif Tissue Int 59:357–365CrossRefPubMed Khan SR, Atmani F, Glenton P, Hou Z, Talham DR, Khurshid M (1996) Lipids and membranes in the organic matrix of urinary calcific crystals and stones. Calcif Tissue Int 59:357–365CrossRefPubMed
11.
go back to reference Khan SR, Shevock PN, Hackett RL (1988) In vitro precipitation of calcium oxalate in the presence of whole matrix or lipid components of the urinary stones. J Urol 139:418–422PubMed Khan SR, Shevock PN, Hackett RL (1988) In vitro precipitation of calcium oxalate in the presence of whole matrix or lipid components of the urinary stones. J Urol 139:418–422PubMed
12.
go back to reference Fasano JM, Khan SR (2001) Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kidney Int 59:169–178CrossRefPubMed Fasano JM, Khan SR (2001) Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kidney Int 59:169–178CrossRefPubMed
13.
go back to reference Khan SR, Maslamani SA, Atmani F, Glenton PA, Opalko FJ, Thamilselvan S, Hammett-Stabler C (2000) Membranes and their constituents as promoters of calcium oxalate crystal formation in human urine. Calcif Tissue Int 66:90–96CrossRefPubMed Khan SR, Maslamani SA, Atmani F, Glenton PA, Opalko FJ, Thamilselvan S, Hammett-Stabler C (2000) Membranes and their constituents as promoters of calcium oxalate crystal formation in human urine. Calcif Tissue Int 66:90–96CrossRefPubMed
14.
go back to reference Khan SR, Glenton PA (1996) Increased urinary excretion of lipids by patients with kidney stones. Br J Urol 77:506–511PubMed Khan SR, Glenton PA (1996) Increased urinary excretion of lipids by patients with kidney stones. Br J Urol 77:506–511PubMed
15.
go back to reference Khan SR, Glenton PA, Backov R, Talham DR (2002) Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones. Kidney Int 62:2062–2072CrossRefPubMed Khan SR, Glenton PA, Backov R, Talham DR (2002) Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones. Kidney Int 62:2062–2072CrossRefPubMed
16.
go back to reference White T, Bursten S, Federighi D, Lewis RA, Nudelman E (1998) High-resolution separation and quantification of neutral lipid and phospholipid species in mammalian cells and sera by multi-one-dimensional thin-layer chromatography. Anal Biochem 258:109–117CrossRefPubMed White T, Bursten S, Federighi D, Lewis RA, Nudelman E (1998) High-resolution separation and quantification of neutral lipid and phospholipid species in mammalian cells and sera by multi-one-dimensional thin-layer chromatography. Anal Biochem 258:109–117CrossRefPubMed
17.
go back to reference Buk SJ, High OB (1986) Periodate oxidation of glycolipids: a borohydride-periodate-Schiff method for ganglioside demonstration in tissue sections. Histochem J 18:228–232CrossRefPubMed Buk SJ, High OB (1986) Periodate oxidation of glycolipids: a borohydride-periodate-Schiff method for ganglioside demonstration in tissue sections. Histochem J 18:228–232CrossRefPubMed
18.
go back to reference Atmani F, Khan SR (2000) Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro. BJU Int 85:621–625CrossRefPubMed Atmani F, Khan SR (2000) Effects of an extract from Herniaria hirsuta on calcium oxalate crystallization in vitro. BJU Int 85:621–625CrossRefPubMed
19.
go back to reference Christmas KG, Gower LB, Khan SR, El-Shall H (2002) Aggregation and dispersion characteristics of calcium oxalate monohydrate: effect of urinary species. J Colloid Interface Sci 256:168–174CrossRefPubMed Christmas KG, Gower LB, Khan SR, El-Shall H (2002) Aggregation and dispersion characteristics of calcium oxalate monohydrate: effect of urinary species. J Colloid Interface Sci 256:168–174CrossRefPubMed
20.
go back to reference Boonla C, Hunapathed C, Bovornpadungkitti S, Poonpirome K, Tungsanga K, Sampatanukul P, Tosukhowong P (2008) Messenger RNA expression of monocyte chemoattractant protein-1 and interleukin-6 in stone-containing kidneys. BJU Int 101:1170–1177CrossRefPubMed Boonla C, Hunapathed C, Bovornpadungkitti S, Poonpirome K, Tungsanga K, Sampatanukul P, Tosukhowong P (2008) Messenger RNA expression of monocyte chemoattractant protein-1 and interleukin-6 in stone-containing kidneys. BJU Int 101:1170–1177CrossRefPubMed
21.
go back to reference Boonla C, Wunsuwan R, Tungsanga K, Tosukhowong P (2007) Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res 35:185–191CrossRefPubMed Boonla C, Wunsuwan R, Tungsanga K, Tosukhowong P (2007) Urinary 8-hydroxydeoxyguanosine is elevated in patients with nephrolithiasis. Urol Res 35:185–191CrossRefPubMed
22.
go back to reference Sheng X, Jung T, Wesson JA, Ward MD (2005) Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents. Proc Natl Acad Sci USA 102:267–272CrossRefPubMed Sheng X, Jung T, Wesson JA, Ward MD (2005) Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents. Proc Natl Acad Sci USA 102:267–272CrossRefPubMed
Metadata
Title
Lithogenic activity and clinical relevance of lipids extracted from urines and stones of nephrolithiasis patients
Authors
Chanchai Boonla
Phantip Youngjermchan
Somkiat Pumpaisanchai
Kriang Tungsanga
Piyaratana Tosukhowong
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Urolithiasis / Issue 1/2011
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-010-0281-6

Other articles of this Issue 1/2011

Urolithiasis 1/2011 Go to the issue